Main Menu

Checkmate Pharmaceuticals, Inc.

(NASDAQ GM: CMPI)

Rigrodsky Law, P.A. is investigating Checkmate Pharmaceuticals, Inc. (“Checkmate”) regarding possible breaches of fiduciary duties and other violations of law related to Checkmate’s agreement to be acquired by Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Checkmate’s shareholders will receive $10.50 in cash for each share of Checkmate common stock they own. 

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 05/17/2022


* Indicates a required field.

Back to Page